These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7701478)

  • 1. Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid.
    Suehisa E; Toku M; Akita N; Fushimi R; Takano T; Tada H; Iwatani Y; Amino N
    Thromb Res; 1995 Jan; 77(1):63-8. PubMed ID: 7701478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
    Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid and Hashimoto's thyroiditis.
    Callen JP; McCall MW
    J Am Acad Dermatol; 1981 Nov; 5(5):558-60. PubMed ID: 7028805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
    Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid and multiple autoimmune diseases. Alopecia universalis, bullous pemphigoid, hypothyroidism, rheumatoid arthritis, and neutropenia in one patient.
    Lynfield YL; Green K; Gopal R
    J Am Acad Dermatol; 1983 Aug; 9(2):257-61. PubMed ID: 6350385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid occurring in psoriatic plaques in association with Hashimoto's thyroiditis.
    Smith WD; Jones MS; Stewart TW; Fernando MU
    Clin Exp Dermatol; 1991 Sep; 16(5):389-91. PubMed ID: 1794194
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
    Zehnder JL; Leung LL
    Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and study of an acquired inhibitor of human coagulation factor V.
    Nesheim ME; Nichols WL; Cole TL; Houston JG; Schenk RB; Mann KG; Bowie EJ
    J Clin Invest; 1986 Feb; 77(2):405-15. PubMed ID: 3944265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen.
    Chan LS; Dorman MA; Agha A; Suzuki T; Cooper KD; Hashimoto K
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):331-5. PubMed ID: 8436652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A long-lasting idiopathic factor V inhibitor].
    Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by immunoglobulin G of synthesis of thyroid hormone in thyroid cultures from hypothyroid patients with goitrous Hashimoto's thyroiditis.
    Noh J; Hamada N; Saito H; Yoshimoto M; Iwasaki H; Ozaki O; Okamoto Y; Ito K; Morii H
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):511-8. PubMed ID: 1979465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
    Seishima M; Izumi T; Kitajima Y
    Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does class switching contribute to remission in bullous pemphigoid?
    Modre B; Allen J; Wojnarowska F
    Acta Derm Venereol; 1999 Mar; 79(2):127-31. PubMed ID: 10228631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V.
    Bänninger H; Hardegger T; Tobler A; Barth A; Schüpbach P; Reinhart W; Lämmle B; Furlan M
    Br J Haematol; 1993 Nov; 85(3):528-32. PubMed ID: 8136275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain.
    Balding SD; Prost C; Diaz LA; Bernard P; Bedane C; Aberdam D; Giudice GJ
    J Invest Dermatol; 1996 Jan; 106(1):141-6. PubMed ID: 8592065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.
    Rico MJ; Korman NJ; Stanley JR; Tanaka T; Hall RP
    J Immunol; 1990 Dec; 145(11):3728-33. PubMed ID: 1700993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.